Wendy K. Glenn

2.0k citations
38 papers · 1.6k indexed · h-index 22
Topics
Cervical Cancer and HPV Research (21 papers)Viral-associated cancers and disorders (9 papers)T-cell and Retrovirus Studies (5 papers)

In The Last Decade

Wendy K. Glenn

37 papers receiving 1.5k citations

Peers

Wendy K. Glenn
Comparison fields: 5 of 114
  • Epidemiology 676
  • Oncology 651
  • Molecular Biology 439
  • Immunology 324
  • Cancer Research 197
Replace Noel J. Whitaker with:
Noel J. Whitaker Australia
Jason J. Chen United States
Lynne Hampson United Kingdom
Nancy E. Joste United States
Valérie Gouyer France
Ezequiel M. Fuentes‐Pananá Mexico
Judy A. Mietz United States
Jon Askaa Denmark
Kevin Gaston United Kingdom
Sudhir Krishna India
Wendy K. Glenn relative to Noel J. Whitaker Australia Noel J. Whitaker's profile →
Citations per field
00.5×1.6×
Noel J. Whitaker · 1×
Citations per year

Countries citing papers authored by Wendy K. Glenn

Since Specialization
Citations

This map shows the geographic impact of Wendy K. Glenn's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Wendy K. Glenn with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Wendy K. Glenn more than expected).

Fields of papers citing papers by Wendy K. Glenn

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Wendy K. Glenn. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Wendy K. Glenn. The network helps show where Wendy K. Glenn may publish in the future.

Co-authorship network of co-authors of Wendy K. Glenn

This figure shows the co-authorship network connecting the top 25 collaborators of Wendy K. Glenn. A scholar is included among the top collaborators of Wendy K. Glenn based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Wendy K. Glenn. Wendy K. Glenn is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
#WorkIndexed citations
1 4
2 5
3 20
4 17
5 35
6 38
7 48
8 32
9 29
10 35
11 73
12 130
13 30
14 52
15 139
16 6
17 48
18 7
19 22
20 82

About Wendy K. Glenn

Wendy K. Glenn is a scholar working on Epidemiology, Immunology and Oncology, having authored 38 papers that have together received 1.6k indexed citations. Recurring topics across this work include Cervical Cancer and HPV Research (21 papers), Viral-associated cancers and disorders (9 papers) and T-cell and Retrovirus Studies (5 papers). The work is most often cited by research in Oncology (651 citations), Epidemiology (676 citations) and Immunology (324 citations). Wendy K. Glenn has collaborated with scholars based in Australia, United States and Italy. Frequent co-authors include James S. Lawson, Noel J. Whitaker, Brian Salmons, Warick Delprado, Benjamin Heng, Louise Lutze‐Mann, Bryan Tran, Barry Iacopetta, Adrienne R. Thompson and EOP Thompson. Their work appears in journals such as The Journal of Immunology, PLoS ONE and Cancer Research.

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026